Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Alessia BariChiara GerardiEleonora AllocatiAgata PuzzovivoVitaliana De SanctisAlessandra TucciMonica BalzarottiSilvia FranceschettiFrancesco MerliAttilio GuariniGuido GiniCarla MinoiaPublished in: Cancers (2022)
Compared to other patients suffering from hematological malignancies, classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) patients have a long life expectancy when in complete remission at the end of first, or sometimes second, line treatments [...].